Recursion former director plans sale of 26,806 shares
RECURSION PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RECURSION PHARMACEUTICALS, INC. (RXRX) is the issuer of Class A common stock for which Christopher C. Gibson, a former director, has filed a Rule 144 notice. The filing covers the proposed sale of 26,806 Class A shares, originating from restricted stock vesting on 08/17/2026, with part of the sale intended to cover a tax obligation from a vested equity award distribution. The notice also lists extensive Class A share sales during the prior three months by Gibson, Lahwran-3 LLC, and the Gibson Family Trust.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock vesting financial
vested equity award distribution financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for RECURSION PHARMACEUTICALS, INC. (RXRX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.